{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:53Z","timestamp":1786120313474,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/coc.0b013e31822dfd55","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T12:50:08Z","timestamp":1322743808000},"page":"600-605","source":"Crossref","is-referenced-by-count":16,"title":["A Phase III Study of Late Course Accelerated Hyperfractionated Radiotherapy Versus Conventionally Fractionated Radiotherapy in Patients With Nasopharyngeal Carcinoma"],"prefix":"10.1097","volume":"35","author":[{"given":"Zi-qiang","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia-yun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-mao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-fu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210128","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijrobp.2004.11.002","article-title":"Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone.","volume":"62","author":"Yeh","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-16-20210128","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2004.07.702","article-title":"Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.","volume":"61","author":"Lee","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-16-20210128","first-page":"335","article-title":"Treatment results of nasopharyngeal carcinoma: a retrospective analysis of 1837 cases in a single institute.","volume":"17","author":"Gao","year":"2008","journal-title":"Chin J Radiat Oncol"},{"key":"R4-16-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.radonc.2008.02.014","article-title":"A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer.","volume":"87","author":"Waldron","year":"2008","journal-title":"Radiother Oncol"},{"key":"R5-16-20210128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1368-8375(01)00034-3","article-title":"Nasopharyngeal cancer WHO type II-III monoinstitutional retrospective analysis with standard and accelerated hyperfractionated radiation therapy.","volume":"38","author":"Franchin","year":"2002","journal-title":"Oral Oncol"},{"key":"R6-16-20210128","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/000348940611501003","article-title":"Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma.","volume":"115","author":"Nomiya","year":"2006","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R7-16-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00066-004-1202-9","article-title":"Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.","volume":"180","author":"Jereczek-Fossa","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"R8-16-20210128","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"R9-16-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-8140(92)90242-M","article-title":"Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of EORTC cooperative group of radiotherapy.","volume":"25","author":"Horiot","year":"1992","journal-title":"Radiother Oncol"},{"key":"R10-16-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003.","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-16-20210128","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"R12-16-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.radonc.2007.08.005","article-title":"Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).","volume":"85","author":"He","year":"2007","journal-title":"Radiother Oncol"},{"key":"R13-16-20210128","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3748\/wjg.v9.i6.1374","article-title":"Late course accelerated hyperfractionated radiotherapy for clinical T1-2 esophageal carcinoma.","volume":"9","author":"Zhao","year":"2003","journal-title":"World J Gastroenterol"},{"key":"R15-16-20210128","first-page":"321","article-title":"Comparison of remote results of conventional fractionation radiotherapy and late course accelerated hyperfractionation radiotherapy for nasopharyngeal carcinoma.","volume":"16","author":"Zhu","year":"2007","journal-title":"Chin J Radiat Oncol"},{"key":"R16-16-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0167-8140(02)00370-5","article-title":"Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma.","volume":"68","author":"Waldron","year":"2003","journal-title":"Radiother Oncol"},{"key":"R17-16-20210128","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.meddos.2007.02.006","article-title":"Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.","volume":"32","author":"Chau","year":"2007","journal-title":"Med Dosim"},{"key":"R18-16-20210128","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0360-3016(00)00786-0","article-title":"Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurogic complications.","volume":"48","author":"Teo","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-16-20210128","first-page":"158","article-title":"Influences of magnetic resonance imaging on the staging system of nasopharyngeal carcinoma.","volume":"26","author":"Sun","year":"2007","journal-title":"Ai Zheng"},{"key":"R20-16-20210128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hed.10378","article-title":"Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy.","volume":"26","author":"Chung","year":"2004","journal-title":"Head Neck"},{"key":"R22-16-20210128","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","article-title":"Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"R23-16-20210128","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ijrobp.2009.01.018","article-title":"Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre Singapore experience.","volume":"75","author":"Tham","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R24-16-20210128","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ijrobp.2008.12.015","article-title":"Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.","volume":"75","author":"Lin","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-16-20210128","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup Study 0099.","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"key":"R26-16-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1053-4296(98)80021-0","article-title":"Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma.","volume":"8","author":"Brizel","year":"1998","journal-title":"Semin Radiat Oncol"},{"key":"R27-16-20210128","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ctrv.2009.01.002","article-title":"Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia.","volume":"35","author":"Lu","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"R28-16-20210128","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1200\/JCO.2005.02.147","article-title":"Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.","volume":"23","author":"Chan","year":"2005","journal-title":"J Clin Oncol"},{"key":"R29-16-20210128","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hed.20792","article-title":"Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma.","volume":"30","author":"Chua","year":"2008","journal-title":"Head Neck"},{"key":"R30-16-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/cncr.25374","article-title":"Phase 2 trial of concurrent 5-fluorourail, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer.","volume":"117","author":"Kao","year":"2011","journal-title":"Cancer"},{"key":"R31-16-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00066-010-2093-6","article-title":"A phase III study of altered fractionated IMRT alone for intermediated T-stage oropharyngeal carcinoma.","volume":"186","author":"Gunn","year":"2010","journal-title":"Strahlenther Onkol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0b013e31822dfd55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:25:40Z","timestamp":1786047940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-201212000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e31822dfd55","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}